Beneficient regains full Nasdaq compliance after bid price and warrants deficiency resolved

Beneficient

Nasdaq notified Beneficient on Jan 2, 2026, that it regained compliance with Listing Rule 5550(a)(2) (bid price) and 5560(a) (warrants).
Company is now in full compliance with all Nasdaq Capital Market listing requirements.
Prior deficiency related to minimum bid price and warrant listing standards has been cured.
Press release issued Jan 5, 2026, confirming the compliance status.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.